Yara Abdou, Assistant Professor at University of North Carolina at Chapel Hill, shared on X:
“AI-driven chart review revealed that 1 in 3 eligible breast cancer patients lacked documented germline testing, with testing rates as low as 42–44% in advanced-stage disease!
Despite clear NCCN guidelines, too many patients are still missing this critical component of cancer care.”
Other articles about germline testing on OncoDaily.